Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

BUD vs ABEV: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ABEV Captures Overall Composite Edge (60.3 BUY vs 34.9 SELL), While BUD Leads 4–1 on Growth & Valuation Pillars

ABEV Overall Winner 6-Pillar Tally: BUD 4 – 1 ABEV (1 Tie) Matrix Metrics: BUD 5 – 5 ABEV

As of Nov 16, 2026, Ambev S.A. (ABEV) captures the overall head-to-head institutional edge over Anheuser-Busch INBEV SA/NV (BUD) on higher Unified Composite conviction (60.3/100 BUY vs. 34.9/100 SELL) after splitting the core matrix 5–5 (led by Valuation Multiples), while BUD wins 4–1 across the 6-pillar growth and valuation breakdown. BUD trades at $84.55 (17.4x Forward P/E, 26.7% operating margin) versus ABEV at $2.71 (13.5x Forward P/E, 26.1% operating margin).

  • Growth vs. Quality Trade-Off: ABEV earns the overall head-to-head edge with a stronger Unified Composite Score (60.3/100 BUY vs. BUD 34.9/100 SELL) and 0.54β · 58% Vol risk profile, whereas BUD leads top-line expansion (+9.1% YoY revenue growth, 1.74x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates.
  • Technical & Structure Timing Caution: BUD trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 57.3); meanwhile ABEV is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BUD vs ABEV
BUD NYSE
Anheuser-Busch INBEV SA/NV
Malt Beverages
$84.55
-0.31% 1D
Market Cap $167.3B
TTM Revenue $64.0B
Forward P/E 17.4x
Beta / 30D Vol 0.23β · 33% Vol
Unified Composite Score
34.9 / 100 SELL
Tech 36.0 Fund 35.0 Flow 50.0 Mom 6.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.0% over 20 days), RSI 57
RSI-14: 57.3 · SMA20: $83.31 · SMA50: $79.97
ABEV NYSE Head-to-Head Winner
Ambev S.A.
Beverages
$2.71
-1.99% 1D
Market Cap $42.6B
TTM Revenue $16.6B
Forward P/E 13.5x
Beta / 30D Vol 0.54β · 58% Vol
Unified Composite Score
60.3 / 100 BUY
Tech 94.0 Fund 66.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -0.3%), weak momentum, RSI 38
RSI-14: 38.2 · SMA20: $2.86 · SMA50: $2.98

6-Pillar Scorecard Institutional Category Breakdown (BUD 4 – 1 ABEV)

Columns: Metric · BUD · ABEV
1. Valuation Multiples ABEV
Forward P/E 17.4x 13.5x
Trailing P/E 17.3x 14.6x
PEG Ratio 1.74x 1.92x
EV / Revenue 2.6x 2.6x
2. Growth & Scale BUD
Revenue Growth (YoY) +9.1% +3.6%
Earnings Growth (YoY) +52.5% -9.4%
TTM Revenue (USD) $64.0B $16.6B
Market Cap $167.3B $42.6B
3. Profitability & Quality BUD
Gross Margin 56.5% 51.8%
Operating Margin 26.7% 26.1%
Net Profit Margin 15.4% 17.7%
Return on Equity (ROE) 11.4% 17.6%
4. Balance Sheet & Cash Flow BUD
Cash Generation (TTM) $20.3B EBITDA $4.96B EBITDA
Cash Flow Margin 31.7% EBITDA Mgn 30.0% EBITDA Mgn
Net Cash / Leverage $7.92 Book/Sh · 11.4% ROE $1.17 Book/Sh · 17.6% ROE
Dividend Yield 1.60% 4.96%
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 23.6% (42nd %ile) 13.5% (<1st %ile)
Put/Call OI Skew Thin ADR Chain Thin ADR Chain
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markdown
6. R&D & Supply-Chain Moat BUD
OpEx & R&D Intensity 29.8% of Rev ($19.1B) 25.7% of Rev ($4.25B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Beverages - Brewers Operator Beverages - Brewers Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BUD (5) vs ABEV (5)
Institutional Metric BUD ABEV Criterion Row Edge
Market Capitalization
Scale
$167.3B $42.6B Larger Scale BUD
Trailing P/E Ratio
Valuation
17.3x 14.6x Lower Multiple ABEV
Forward P/E Ratio
Valuation
17.4x 13.5x Lower Multiple ABEV
Revenue Growth (YoY)
Growth
+9.1% +3.6% Higher Growth BUD
Operating Margin (TTM)
Profitability
26.7% 26.1% Higher Margin BUD
Net Profit Margin
Profitability
15.4% 17.7% Higher Margin ABEV
Return on Equity (ROE)
Capital Efficiency
11.4% 17.6% Higher ROE ABEV
52-Week Range Position
Momentum
92% ($60–$87) 36% ($2–$3) Stronger Trend BUD
Beta / 30D Volatility
Risk Regime
0.23β · 33% Vol 0.54β · 58% Vol Lower Realized Risk BUD
Unified Institutional Score
Composite Signal
34.9 / 100 (SELL) 60.3 / 100 (BUY) Higher Composite ABEV
Trailing 12M Revenue (USD)
Operating Scale
$64.0B $16.6B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
56.5% 51.8% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
1.74x PEG · 2.6x EV/Rev 1.92x PEG · 2.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$20.3B EBITDA ($7.92 Book/Sh · 11.4% ROE) $4.96B EBITDA ($1.17 Book/Sh · 17.6% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon BUD +20.15 pp
BUD: +2.37% · ABEV: -17.78%
3M Horizon BUD +11.89 pp
BUD: +9.19% · ABEV: -2.7%
6M Horizon BUD +17.82 pp
BUD: +3.97% · ABEV: -13.85%
1Y Horizon BUD +23.58 pp
BUD: +30.92% · ABEV: +7.34%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BUD vs ABEV. Trailing 12-month operating profitability (BUD 26.7% vs ABEV 26.1%) and valuation multiples (BUD 17.4x vs ABEV 13.5x Forward P/E) are benchmarked directly in Pillar 4 below.

BUD ADR TTM Benchmark FX-Normalized USD
TTM Revenue$64.0B
Gross Margin56.5%
Op. Margin26.7%
ROE / Fwd P/E11.4% · 17.4x
ABEV ADR TTM Benchmark FX-Normalized USD
TTM Revenue$16.6B
Gross Margin51.8%
Op. Margin26.1%
ROE / Fwd P/E17.6% · 13.5x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BUD UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 23.6%
IV Percentile 42nd %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BUD Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ABEV UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 13.5%
IV Percentile <1st %ile
Put/Call OI Skew Thin ADR Chain
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact ABEV Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BUD Moat Profile Scale & Operating Efficiency Moat
Beverages - Brewers Operator
Competes within the Beverages - Brewers value chain with $167.3B market capitalization and 26.7% operating margin.
OpEx & R&D Reinvestment 29.8% of Rev ($19.1B)
90D Engineering Disclosures 0 Published
ABEV Moat Profile Scale & Operating Efficiency Moat
Beverages - Brewers Operator
Competes within the Beverages - Brewers value chain with $42.6B market capitalization and 26.1% operating margin.
OpEx & R&D Reinvestment 25.7% of Rev ($4.25B)
90D Engineering Disclosures 0 Published

Investor FAQ BUD vs ABEV Key Questions & Quantitative Answers

As of Nov 16, 2026, Ambev S.A. (ABEV) captures the overall head-to-head institutional edge over Anheuser-Busch INBEV SA/NV (BUD) on higher Unified Composite conviction (60.3/100 BUY vs. 34.9/100 SELL) after splitting the core matrix 5–5 (led by Valuation Multiples), while BUD wins 4–1 across the 6-pillar growth and valuation breakdown. BUD trades at $84.55 (17.4x Forward P/E, 26.7% operating margin) versus ABEV at $2.71 (13.5x Forward P/E, 26.1% operating margin). Growth vs. Quality Trade-Off: ABEV earns the overall head-to-head edge with a stronger Unified Composite Score (60.3/100 BUY vs. BUD 34.9/100 SELL) and 0.54β · 58% Vol risk profile, whereas BUD leads top-line expansion (+9.1% YoY revenue growth, 1.74x PEG, and 4 of 6 institutional pillars) for higher-beta growth mandates. Technical & Structure Timing Caution: BUD trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 57.3); meanwhile ABEV is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 38.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

BUD leads the Growth & Scale pillar: BUD posts +9.1% YoY revenue growth and +52.5% YoY earnings growth on $64.0B TTM revenue (56.5% gross margin, 26.7% operating margin), compared with ABEV at +3.6% YoY revenue growth and -9.4% YoY earnings growth on $16.6B TTM revenue (51.8% gross margin, 26.1% operating margin). On trailing 12-month operating scale, BUD generates $64.0B in USD-normalized revenue versus $16.6B for ABEV. In operating R&D and SG&A reinvestment, BUD deploys 29.8% of Rev ($19.1B) (0 90-day corporate R&D disclosures) versus 25.7% of Rev ($4.25B) (0 disclosures) for ABEV.

ABEV screens cheaper on headline valuation multiples. BUD trades at 17.4x Forward P/E, 17.3x Trailing P/E, 1.74x PEG, and 2.6x EV/Revenue (31.7% EBITDA margin), whereas ABEV trades at 13.5x Forward P/E, 14.6x Trailing P/E, 1.92x PEG, and 2.6x EV/Revenue (30.0% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BUD (11.4% ROE) versus ABEV (17.6% ROE) capital efficiency.

In options market volatility and institutional positioning, BUD carries 23.6% implied volatility (42nd %ile, Balanced (25th–60th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.23β · 33% Vol realized risk). By comparison, ABEV carries 13.5% implied volatility (<1st %ile, Compressed (<25th %ile)), thin ADR options open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.54β · 58% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.